Sollis Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-04-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.sollistx.com
Sciatica Epidural Radiculopathy Experimental New Interventional TherapY Clonidine Micropellet
Phase 3
Terminated
- Conditions
- Lumbosacral Radiculopathy
- Interventions
- Device: Tuohy epidural needle
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Sollis Therapeutics, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT05614648
- Locations
- 🇺🇸
St. Louis Pain Consultants (site 134), Chesterfield, Missouri, United States
🇺🇸AMPM Research Clinic (site 106), Miami, Florida, United States
🇺🇸Pima Pain Center (site 125), Tucson, Arizona, United States
Long-Term Follow-up Safety of Clonidine Micropellets
Completed
- Conditions
- Lumbosacral Radiculopathy
- Interventions
- Drug: Long-Term Safety Follow-up
- First Posted Date
- 2018-12-14
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Sollis Therapeutics, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT03776318
- Locations
- 🇺🇸
Sollis Clinical Study Site 35, Fort Lauderdale, Florida, United States
🇺🇸Sollis Clinical Study Site 23, Morgantown, West Virginia, United States
🇺🇸Sollis Clinical Study Site 33, Cleveland, Ohio, United States
Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
Phase 3
Completed
- Conditions
- Lumbosacral Radiculopathy
- Interventions
- Combination Product: Clonidine MicropelletsOther: Sham
- First Posted Date
- 2018-11-01
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Sollis Therapeutics, Inc.
- Target Recruit Count
- 207
- Registration Number
- NCT03727100
- Locations
- 🇺🇸
Sollis Clinical Study Site 35, Fort Lauderdale, Florida, United States
🇺🇸Sollis Clinical Study Site 14, Kansas City, Kansas, United States
🇺🇸Sollis Clinical Study Site 16, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath